tirzepatide and cardiovascular outcomes In patients with type 2 diabetes atherosclerotic disease, was noninferior to dulaglutide with respect to major cardiovascular events. ⁣, ⁣, Read the full SURPASS-CVOT Comparative Cardiovascular Pharmacovigilance of Semaglutide

NASH Treatment: Helps manage non-alcoholic steatohepatitis (fatty liver disease)

We take the time to understand your goals and create a plan that fits your unique needswhether it's wellness, primary care needs, or psychiatric needs

The sooner we recognize and diagnose, the quicker we can get these patients to surgery to speed their road to recovery

These injectable weight loss medications are designed to be a treatment for chronic obesity and will only work when they are being taken

Clinical Evidence for Combined Treatment Robust clinical trial data supports the use of metformin and semaglutide in combination for patients with type 2 diabetes and obesity

The Bridge runs through December 31, 2027 and includes: Wegovy (semaglutide) weekly injection for weight loss Zepbound (tirzepatide) weekly injection for weight loss Foundayo (orforglipron) the new daily pill for weight loss Coverage is automatic